KITCHENER - Cloud DX (TSXV: CDX) (OTCQB: CDXFF), a leading North American provider of virtual care and remote patient monitoring platforms is pleased to announce that it hopes that 100% of clients whose contracts are expiring in the first quarter of 2024 will renew.

Of 14 potential renewals, 11 are renewed as of this date with 3 more.

Cloud DX executes contracts with several types of healthcare providers. These contracts typically vary in length from 12 months to a maximum of 84 months. Customers typically purchase Connected Health Kits that include approved medical devices and, in many cases, a customized tablet computer, connected to the internet using WiFi or cellular technology. Patients are prescribed a Connected Health Kit and attached subscription for chronic care management, post-surgical recovery, remote rehabilitation, or palliative care use cases. Using the included medical devices patients gather vital signs, and on the Cloud DX mobile app they answer surveys, receive care plan reminders, and communicate with their care team by text and video chat.

The customers renewing their contracts in the first quarter include 3 Canadian hospitals, 2 Alberta primary care clinics, 2 Ontario family health teams, 5 Ontario community paramedic services, the Canadian Lung Health Foundation and a Canadian Provincial health ministry.

Together these clients enrolled approximately 2,900 unique patients in 2023. Upon renewal of these contracts the Company has received orders for Connected Health Kits valued at $96,000 CAD. Recurring subscription revenues from these contracts is expected to increase to $575,000 CAD per year for a total of $1.5 million CAD in contract value to December 31, 2025. Cloud DX earns approximately 77% gross margins as stated in the Company's most recent Financial Statements.

From January 1, 2024, Cloud DX has announced new contracts or renewals valued at $4.6M, along with new Master Deployment Agreements with VHA HomeHealth Care, the Ottawa Hospital Research Institute and a Master Partnership Agreement with Sanrai International that includes distribution opportunities with Sanrai dealers in 65 countries around the world.

Cloud DX Founder and CEO Robert Kaul stated: 'Cloud DX is happy to report that so far in 2024, all the contracts up for renewal have in fact renewed. Combined with the new contracts announced to date, it's clear that Cloud DX is executing well on our previously noted plan to grow our Canadian business rapidly. Our 100% contract renewal rate is one example of customer confidence in Cloud DX and comes just after the announcement of the early conversion of convertible debentures, followed by the escrow of 26 million shares, showing equally strong confidence from investors.'

About Cloud DX

Accelerating digital healthcare, Cloud DX is on a mission to make healthcare better for everyone. Our Connected Health remote patient monitoring platform is used by healthcare enterprises and care teams across North America to virtually manage chronic disease, enable aging in place, and deliver hospital-quality post-surgical care in the home. Our partners achieve better healthcare and patient outcomes, reduce the need for hospitalization or re-admission, and reduce healthcare delivery costs through more efficient use of resources. Cloud DX is the co-winner of the Qualcomm Tricorder XPRIZE, winner of '2022 Top Innovator' from Canadian Business, a 2021 'Edison Award' winner, a Fast Company 'World Changing Idea' finalist, and one of 'Canada's Ten Most Prominent Telehealth Providers.' Cloud DX is an exclusive partner to Medtronic Canada, Teladoc Health Canada and Sanrai International.

Contact:

Tel: 888-543-0944

Email: marketing@clouddx.com

Jay Bedard

Tel: 647-881-8418

Email: investors@clouddx.com

Forward Looking Statements

This news release contains forward-looking statements and information within the meaning of applicable securities legislation. Often, but not always, forward-looking statements and information can be identified by the use of words such as 'plans', 'expects' or 'does not expect', 'is expected', 'estimates', 'intends', 'anticipates' or 'does not anticipate', or 'believes', or variations of such words and phrases or state that certain actions, events or results 'may', 'could', 'would', 'might' or 'will' be taken, occur or be achieved. Forward looking statements or information involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements or information contained in this news release. In particular, this news release includes certain forward-looking statements concerning the terms of the contract extension, the expected proceeds therefrom, as well as management's objectives, strategies, beliefs and intentions.

Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information. In making the forward-looking statements in this news release, the Company has applied several material assumptions, including without limitation, the Company's the ability of the Company to fulfill the terms of and derive the benefits from the contract extension.

Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information.

(C) 2024 Electronic News Publishing, source ENP Newswire